Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.
about
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialThe Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population.A closer look at hepatitis C clearance in HIV controllers: a response.HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.
P2860
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@ast
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@en
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@nl
type
label
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@ast
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@en
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@nl
prefLabel
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@ast
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@en
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@nl
P2093
P2860
P50
P1433
P1476
Human leukocyte antigen B*57 d ...... clearance in HIV controllers.
@en
P2093
Alice K Asher
Emily K Dokubo
Glenn-Milo Santos
Jeffrey N Martin
Jennifer Evans
Kimberly Page
Leslie H Tobler
Peter W Hunt
P2860
P304
P356
10.1097/01.AIDS.0000433242.86362.21
P407
P577
2013-11-01T00:00:00Z